1.01
price up icon8.57%   0.0797
after-market Handel nachbörslich: 1.00 -0.01 -0.99%
loading

NanoViricides Inc Aktie (NNVC) Neueste Nachrichten

pulisher
Apr 02, 2026

NNVC Stock Price, Quote & Chart | NANOVIRICIDES INC (NYSEARCA:NNVC) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Small caps wrap: Alvopetro Energy, NanoViricides, New Era Energy & Digital, Digi Power X… - proactiveinvestors.co.uk

Apr 01, 2026
pulisher
Apr 01, 2026

NanoViricides to Begin Phase II MPox Clinical Trial in Democratic Republic of Congo - citybuzz -

Apr 01, 2026
pulisher
Apr 01, 2026

Small cap wrap: Alvopetro Energy, NanoViricides, New Era Energy & Digital, Digi Power X… - Proactive financial news

Apr 01, 2026
pulisher
Apr 01, 2026

NanoViricides to begin Phase II trial of MPox treatment in Congo - Proactive financial news

Apr 01, 2026
pulisher
Apr 01, 2026

Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides - ACCESS Newswire

Apr 01, 2026
pulisher
Apr 01, 2026

Monkeypox drug trial cleared in Congo as NanoViricides readies dosing - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

Tangible book value per share of NanoViricides, Inc. – MUN:NV3P - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

Forecast Cut: Is NanoViricides Inc subject to activist investor interest2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

Reviewing NanoViricides (NYSE:NNVC) & Spruce Biosciences (NASDAQ:SPRB) - Defense World

Mar 30, 2026
pulisher
Mar 29, 2026

NNVC Should I Buy - Intellectia AI

Mar 29, 2026
pulisher
Mar 28, 2026

Growth Recap: Should I hold or sell NanoViricides Inc nowTrade Ideas & Risk Controlled Daily Plans - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 25, 2026

Aug Retail: Can NanoViricides Inc generate free cash flowEarnings Beat & Real-Time Volume Analysis - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

NanoViricides (NYSE:NNVC) Stock Price Down 4.8% – What’s Next? - Defense World

Mar 24, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Nanoviricides (NNVC) - Stock Titan

Mar 22, 2026
pulisher
Mar 16, 2026

EBITDA per share of NanoViricides, Inc. – FWB:NV3P - TradingView

Mar 16, 2026
pulisher
Mar 13, 2026

Volume Recap: Can NanoViricides Inc grow without external funding2026 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 12, 2026

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - Beaver County Times

Mar 12, 2026
pulisher
Mar 12, 2026

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides - The Register-Guard

Mar 12, 2026
pulisher
Mar 12, 2026

NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - The Asheville Citizen Times

Mar 12, 2026
pulisher
Mar 12, 2026

NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete - ACCESS Newswire

Mar 12, 2026
pulisher
Mar 11, 2026

NanoViricides Completes Manufacturing of NV-387 Oral Gummies, Prepares for Phase II Monkeypox Trial - citybuzz -

Mar 11, 2026
pulisher
Mar 11, 2026

Aug Setups: Can NanoViricides Inc continue delivering strong returns2026 EndofMonth & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 11, 2026

Small cap wrap: NanoViricides, Millennial Potash, Gunnison Copper, Century Lithium… - Proactive Investors

Mar 11, 2026
pulisher
Mar 11, 2026

NanoViricides completes manufacturing of NV-387 oral drug ahead of Phase II mpox trial - Yahoo! Finance Canada

Mar 11, 2026
pulisher
Mar 11, 2026

Antiviral NV-387 heads to Phase II mpox trial with new gummy form - Stock Titan

Mar 11, 2026
pulisher
Mar 10, 2026

Jobs Data: Can NanoViricides Inc continue delivering strong returnsMarket Volume Report & Community Verified Trade Signals - baoquankhu1.vn

Mar 10, 2026
pulisher
Mar 06, 2026

Sell Signal: Is NanoViricides Inc subject to activist investor interest2025 Investor Takeaways & Low Risk Growth Stock Ideas - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

NNVC Earnings History & Surprises | EPS & Revenue Results | NANOVIRICIDES INC (NYSEARCA:NNVC) - ChartMill

Mar 04, 2026
pulisher
Mar 02, 2026

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - The Asheville Citizen Times

Mar 02, 2026
pulisher
Mar 01, 2026

getLinesFromResByArray error: size == 0 What is NanoViricides Inc.’s TAM (Total Addressable Market)Portfolio Gains Report & Growth Focused Entry Reports - mfd.ru

Mar 01, 2026
pulisher
Feb 24, 2026

NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres - The Clarion-Ledger

Feb 24, 2026
pulisher
Feb 23, 2026

US Stocks Recap: Is NanoViricides Inc forming a breakout patternJuly 2025 WrapUp & Community Trade Idea Sharing - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

Aug Fed Impact: Can NanoViricides Inc continue delivering strong returnsQuarterly Earnings Report & Long-Term Safe Investment Plans - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 22, 2026

NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387ICYMI - Proactive financial news

Feb 22, 2026
pulisher
Feb 21, 2026

Growth Value: Will NanoViricides Inc benefit from rate cutsJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

Small cap wrap: Aftermath Silver, M2i Global, NanoViricides, AtaiBeckley… - Proactive financial news

Feb 20, 2026
pulisher
Feb 19, 2026

NanoViricides advances toward fully funded Phase II MPox trial in DRC - Proactive financial news

Feb 19, 2026
pulisher
Feb 19, 2026

NanoViricides advances broad-spectrum antiviral NV-387 towards Phase II MPox study - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

NanoViricides advances toward fully funded Phase II MPox trial in DRC | NYSE-A:NNVC - Proactive financial news

Feb 19, 2026
pulisher
Feb 17, 2026

NanoViricides: Fiscal Q2 Earnings Snapshot - kare11.com

Feb 17, 2026
pulisher
Feb 17, 2026

NanoViricides: Fiscal Second Quarter Earnings Overview - Bitget

Feb 17, 2026
pulisher
Feb 15, 2026

Moving Averages: Is NanoViricides Inc exposed to political riskJuly 2025 Movers & Growth Focused Stock Reports - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 13, 2026

Can NanoViricides Inc grow without external fundingJuly 2025 Review & Growth Focused Stock Reports - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... - Proactive financial news

Feb 12, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):